Publication: Endoglin -CD105- immuno expression in human foetal and neonatal lungs
| dc.contributor.author | Barresi, Valeria | es |
| dc.contributor.author | Grosso, Maddalena | es |
| dc.contributor.author | Vitarelli, Enrica | |
| dc.contributor.author | Granese, Roberta | |
| dc.contributor.author | Barresi, G. | |
| dc.date.accessioned | 2013-01-22T10:01:53Z | |
| dc.date.available | 2013-01-22T10:01:53Z | |
| dc.date.issued | 2008 | |
| dc.description.abstract | Endoglin is a 180 KDa glycoprotein mainly expressed on endothelial cells of newly formed vessels. Its expression is increased by the hypoxia inducible factor 1 (HIF-1), a potent stimulator of VEGF expression. The relative hypoxic environment in which foetal lung develops favours HIF-1 dependent gene expression, including the endoglin and VEGF ones. Herein, we analysed endoglin immunoexpression in the human neonatal and foetal lung throughout gestation. Lungs from 18 foetuses (9-41 weeks), 7 preterm and 2 term infants were submitted to the immunohistochemical study. A slight immunostaining was found in some mesenchymal aggregates in the lungs of foetuses at the first trimester of pregnancy. At mid gestation, endoglin was evidenced in peri-tubular mesenchymal stem cells or in peri-canalicular vessels and in the endothelia of peri-bronchial vessels; by contrast, no immunoreaction was observed in case of Down syndrome or in a foetus with cardiac malformations. At late gestation and in preterm infants, endoglin antibody labelled endothelia of the alveolar capillaries and of peri-bronchial vessels. In case of alveolar capillary dysplasia (ACD) or macrosomy associated with maternal diabetes, endoglin expression was restricted to peri-bronchial vessels; no immunoreaction was encountered in foetuses with IUGR (intra-uterine growth restriction) or massive pulmonary haemorrhage. Lungs of term infants both displayed atelectasis; there was no evidence of endoglin immunoexpression in one case, whereby only the endothelia of peri-bronchial vessels were stained in the other. Our study suggests that lung vasculogenesis endures throughout gestation. Absence of endoglin staining in some pathologic conditions may reflect lung vasculogenesis disorders; nonetheless, since each pathologic state is represented by a single case in our cohort, further studies are required to clarify this issue. | es |
| dc.format | application/pdf | es |
| dc.format.extent | 8 | es |
| dc.identifier.issn | 0213-3911 | es |
| dc.identifier.uri | http://hdl.handle.net/10201/29819 | |
| dc.language | eng | es |
| dc.publisher | Murcia : F. Hernández | es |
| dc.relation.ispartof | Histology and histopathology | es |
| dc.rights | info:eu-repo/semantics/openAccess | es |
| dc.subject | Endoglin | es |
| dc.subject | Foetus | es |
| dc.subject.other | 618 - Ginecología. Obstetricia | es |
| dc.title | Endoglin -CD105- immuno expression in human foetal and neonatal lungs | es |
| dc.type | info:eu-repo/semantics/article | es |
| dspace.entity.type | Publication | es |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Endoglin -CD105- immuno expression in human foetal and neonatal lungs.pdf
- Size:
- 4.25 MB
- Format:
- Adobe Portable Document Format
- Description:
Sin licencia Creative Commons.